Cardiomo is a United States based startup that offers wearable remote cardiac monitoring powered by a proprietary AI engine. The company's slogan "provides wearable remote cardiac monitoring using a proprietary AI engine to enable early warnings in real time" epitomizes their core offering. Founded in 2016, Cardiomo has developed a miniature wearable patch equipped with sensors to record ECG, respiration, skin temperature, and body movement. This data, along with vitals registered through a mobile app, is analyzed by Cardiomo's AI engine in a HIPAA compliant cloud to detect cardiovascular disease (CVD) symptoms. The end-user app provides consumer-friendly vital information while the practitioner dashboard aids faster medical inference with various bio-medical data markers. The startup secured a grant investment at 14 September 2021 from the Ukrainian Startup Fund. With a focus on AI, hardware, health care, medical devices, and machine learning, Cardiomo targets individuals serious about their health, as well as their loved ones, positioning its product as a necessity for people with CVD risk factors, elderly relatives and friends, young sports athletes, and health enthusiasts. This innovative approach positions Cardiomo as an attractive investment opportunity with the potential to transform the health monitoring industry.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Grant | Unknown | 1 | Ukrainian Startup Fund | 14 Sep 2021 |
Seed Round | $100.00K | - | 01 Aug 2020 | |
Pre Seed Round | €95.00K | 1 | 28 Aug 2019 | |
Grant | €50.00K | - | 15 Apr 2019 | |
Pre Seed Round | $120.00K | - | 01 Feb 2019 |
No recent news or press coverage available for Cardiomo.